TY - JOUR
T1 - Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome
AU - Sato, Yusuke
AU - Maekawa, Shigekatsu
AU - Ishii, Ryohei
AU - Sanada, Masashi
AU - Morikawa, Teppei
AU - Shiraishi, Yuichi
AU - Yoshida, Kenichi
AU - Nagata, Yasunobu
AU - Sato-Otsubo, Aiko
AU - Yoshizato, Tetsuichi
AU - Suzuki, Hiromichi
AU - Shiozawa, Yusuke
AU - Kataoka, Keisuke
AU - Kon, Ayana
AU - Aoki, Kosuke
AU - Chiba, Kenichi
AU - Tanaka, Hiroko
AU - Kume, Haruki
AU - Miyano, Satoru
AU - Fukayama, Masashi
AU - Nureki, Osamu
AU - Homma, Yukio
AU - Ogawa, Seishi
PY - 2014
Y1 - 2014
N2 - Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome.The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.
AB - Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome.The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.
UR - http://www.scopus.com/inward/record.url?scp=84901217805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901217805&partnerID=8YFLogxK
U2 - 10.1126/science.1252328
DO - 10.1126/science.1252328
M3 - Article
C2 - 24855271
AN - SCOPUS:84901217805
SN - 0036-8075
VL - 344
SP - 917
EP - 920
JO - Science
JF - Science
IS - 6186
ER -